Skip to main content

Table 1 Description of the genetic changes in 32 participants with 22q13 deletions or SHANK3 mutations

From: Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency

Patient

Gender

Ascertainment method

Rearrangement

Del 22q13, array coordinates (hg19)

Del 22q13 size

Validation

Inheritance

Additional genomic findings

SH1

Male

Karyotype, FISH

Ring 22

48927548-51224208

2,296,661

MLPA

Mother negative

None

SH2

Male

Karyotype, aCGH

Ring 22

48444959-51224208

2,779,250

MLPA

De novo

None

SH3

Male

Karyotype, SNP array

Ring 22

49114430-51224208

2,109,779

MLPA

De novo

None

SH4

Female

aCGH

Terminal deletion

44321641-51224208

6,902,568

MLPA

De novo

None

SH5

Male

aCGH

Terminal deletion

46143471-51224208

5,080,738

MLPA

De novo

None

SH6

Female

aCGH, FISH

Terminal deletion

44427703-51224208

6,796,506

MLPA

De novo

None

SH7

Female

Karyotype, FISH

Ring 22

46905533-51224208

4,318,676

MLPA

Mother negative

None

SH8

Female

aCGH, and FISH

Terminal deletion

49574124-51224208

1,650,085

MLPA

De novo

None

SH9

Female

aCGH, FISH

Terminal deletion

49028732-51224208

2,195,477

MLPA

De novo

None

SH10

Male

SNP microarray

Terminal deletion

51122946-51224208

101,263

MLPA

De novo

None

SH11

Female

aCGH, FISH

Terminal deletion

49028732-51224208

2,195,477

MLPA

De novo

None

SH12

Male

aCGH

Terminal deletion

42773732-51224208

8,450,477

MLPA

De novo

None

SH13

Female

Karyotype

Terminal deletion

43745129-51224208

7,479,080

MLPA

De novo

None

SH14

Female

aCGH, FISH

Unbalanced translocation

50267252-51224208

956,957

MLPA

De novo

None

SH15

Female

SNP microarray

Terminal deletion

45902119-51224208

5,322,090

MLPA

De novo

None

SH16

Female

CMA, FISH

Terminal deletion

42918711-51224208

8,305,498

MLPA

Father negative

None

SH17

Female

SNP microarray

Terminal deletion

45583935-51224208

5,640,274

MLPA

De novo

None

SH18

Female

aCGH, FISH

Terminal deletion

50077362-51224208

1,146,847

MLPA

De novo

None

SH19

Male

FISH

Interstitial deletion

48551989-51206201

2,654,212

MLPA

Father negative

None

SH20

Male

aCGH

Terminal deletion

51083118-51224208

141,091

MLPA

De novo

None

SH21

Male

aCGH

Terminal deletion

45428606-51224208

5,795,603

MLPA

De novo

None

SH22

Male

FISH

Terminal deletion

44800014-51224208

6,424,195

MLPA

De novo

None

SH23

Male

Karyotype, FISH

Unbalanced translocation

44023173-51224208

7,201,036

MLPA

De novo

None

SH24

Male

Karyotype, aCGH

Ring 22

43218614-51224208

8,005,595

MLPA

De novo

None

SH25

Male

aCGH, FISH

Terminal deletion

46787434-51224208

4,436,775

MLPA

De novo

None

SH26

Male

Karyotype, FISH

Ring 22

49460840-51224208

1,763,369

MLPA

De novo deletion; maternal balanced translocation, 46,XX, t(1;6)(p13.3;q22,2)

None

SH27a

Male

SNP microarray

Terminal deletion

51115526-51234443

118,917

no DNA, validated in a clinical lab

De novo deletion; maternal balanced translocation, 46,XX, t(11;22)(q23;q11.2)

None

SH28

Female

aCGH, FISH

Terminal deletion

45705241-51224208

5,518,968

MLPA

De novo

None

SH29

Male

Sequencing

SHANK3 frameshift mutation (c.2497delG)

No 22q13 deletion detected

 

Sanger sequencing

De novo

None

SH30

Female

FISH

Terminal deletion

49004395-51224208

2,219,814

MLPA

Father negative

None

SH31

Male

aCGH

Terminal deletion

42822943-51224208

8,401,266

MLPA

Mother negative

None

SH32

Male

Sequencing

SHANK3 nonsense mutation (c.1527G>A)

No 22q13 deletion detected

 

Sanger sequencing

De novo

De novo 17q12 microduplication (chr17:34815184–36249059)b

  1. aNo blood was available for participant SH27 or his parents so we present the findings of the clinical report, which used the Affymetrix 6.0 platform. bReported previously [45]. aCGH, array comparative genomic hybridization; CMA, chromosomal microarray analysis; FISH, fluorescent in situ hybridization; hg, human genome version; MLPA, multiplex ligation-dependent probe amplification; SNP, single nucleotide polymorphism.